Plasma Concentrations of Myeloperoxidase Predict Mortality After Myocardial Infarction

This publication has 40 references indexed in Scilit:

• Plasma Myeloperoxidase Levels in Patients With Chronic Heart Failure
  The American Journal of Cardiology, 2006
• Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure
  Published by Elsevier ,2006
• Angiotensin Type-1 Receptor A1166C Gene Polymorphism Correlates With Oxidative Stress Levels in Human Heart Failure
  Hypertension, 2006
• Heparins Increase Endothelial Nitric Oxide Bioavailability by Liberating Vessel-Immobilized Myeloperoxidase
  Circulation, 2006
• Myeloperoxidase as a Marker of Hemodialysis Biocompatibility and Oxidative Stress: The Underestimated Modifying Effects of Heparin
  American Journal of Kidney Diseases, 2006
• Statins downregulate myeloperoxidase gene expression in macrophages
  Biochemical and Biophysical Research Communications, 2005
• Myeloperoxidase and Plasminogen Activator Inhibitor 1 Play a Central Role in Ventricular Remodeling after Myocardial Infarction
  The Journal of Experimental Medicine, 2003
• Disease Stage-Dependent Accumulation of Lipid and Protein Oxidation Products in Human Atherosclerosis
  The American Journal of Pathology, 2002
• Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment
  Clinical Endocrinology, 1997
• Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.
  Journal of Clinical Investigation, 1994